Control Bionics Limited

Equities

CBL

AU0000114183

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 11:59:33 2024-04-25 pm EDT 5-day change 1st Jan Change
0.043 AUD 0.00% Intraday chart for Control Bionics Limited -2.27% -6.52%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Control Bionics Registers Wearable Device with UK Medical Regulator MT
Control Bionics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Control Bionics Secures US Grant Funding to Develop Autonomous Wheelchair Device MT
Control Bionics Raises AU$1 Million Via Shortfall Placement MT
Control Bionics Receives AU$480,500 R&D Tax Rebate MT
Control Bionics Launches NeuroStrip Wearable Device MT
Control Bionics Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Control Bionics Limited Provides Revenue Guidance for the Year Ended 30 June 2023 CI
Control Bionics Limited Announces Unaudited Sales Results for the Month Ended May 2023 CI
Control Bionics Limited Announces Directorate Changes CI
Control Bionics Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Investments in Indonesia's nickel industry RE
Control Bionics Limited Announces Board Changes CI
Control Bionics Limited Announces CEO Changes CI
6,933,538 Options of Control Bionics Limited are subject to a Lock-Up Agreement Ending on 7-DEC-2022. CI
42,818,796 Ordinary Shares of Control Bionics Limited are subject to a Lock-Up Agreement Ending on 7-DEC-2022. CI
Control Bionics CEO Resigns MT
Control Bionics Limited Announces Resignation of Rob Wong as CEO CI
Control Bionics Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Control Bionics Limited Auditor Raises 'Going Concern' Doubt CI
Control Bionics Declares Fiscal Q4, FY22 Cash Receipts MT
Control Bionics Limited Appoints Dominik Kucera as Its Chief Financial Officer on an Interim Basis CI
Control Bionics Limited Announces Resignation of CFO CI
Control Bionics Logs $920,000 Cash Receipts in Fiscal Q3 MT
Control Bionics Expands to Japan with Distributor Deal MT
Chart Control Bionics Limited
More charts
Control Bionics Limited is a medical device company engaged in the development, commercialization and sale of assistive communications technology systems within the disability sector. It assists patients whose ability to communicate verbally or through text and social media is compromised by illnesses, such as motor neuron disease, amyotrophic lateral sclerosis, and others. Its NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as Electromyography output. This output is then sent wirelessly through the NeuroNode to a personal computer, enabling speech and other computer-controlled functions, such as email and texting. Its core systems include NeuroNode Trilogy, NeuroNode Duo, Eye-gaze Duo, and DROVE. Its technology is integrated with eye-gaze technology, whereby the eye gaze enables a cursor to be moved on a computer screen, driven like a mouse, and the NeuroNode acts like the mouse button.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CBL Stock
  4. News Control Bionics Limited
  5. Control Bionics Raises AU$1 Million Via Shortfall Placement